Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Vitura Finalises Candor Medical Acquisition Expanding Digital Health Reach
    • News

    Vitura Finalises Candor Medical Acquisition Expanding Digital Health Reach

    Industry Sees Growth in Digital Health and Medicinal Cannabis The digital health and medicinal cannabis sectors are rapidly evolving, with demand for telehealth services and alternative treatments on the rise. Vitura Health Limited (ASX:VIT) is capitalising on this opportunity, having officially completed its acquisition of Candor Medical, a provider of innovative prescription treatments via telehealth.

    Read More
    Public
  • Clean Seas Seafood Weighs Indicative Merger Proposal from Yumbah
    • News

    Clean Seas Seafood Weighs Indicative Merger Proposal from Yumbah

    Aquaculture Sector Sees Major Opportunity The Australian aquaculture industry is on the brink of a significant shake-up as Clean Seas Seafood Limited (ASX:CSS) considers a merger proposal from Yumbah Aquaculture Ltd. If successful, the deal would combine two leading Australian seafood producers, bringing together Clean Seas’ premium Yellowtail Kingfish operations with Yumbah’s extensive shellfish portfolio.

    Read More
    Public
  • Meridian Moves to Acquire NZ Windfarms in Landmark Deal
    • News

    Meridian Moves to Acquire NZ Windfarms in Landmark Deal

    Wind Energy Opportunity Expands in New Zealand The renewable energy sector in New Zealand is poised for significant growth, with Meridian Energy Limited (ASX/NZX:MEL) announcing its intention to acquire full ownership of NZ Windfarms Limited (NZX:NZWF). The acquisition will provide Meridian with complete control over NZ Windfarms’ assets, including the pivotal Te Rere Hau Wind

    Read More
    Public
  • The RBA’s benchmark interest rate reduced to 4.10%
    • News

    The RBA’s benchmark interest rate reduced to 4.10%

    In a move that has brought a smile to the faces of personal and business borrower alike (and a few under-the-pump politicians!), the Reserve Bank of Australia (RBA) reduced its benchmark interest rate by 25 basis points to 4.10% at its 17-18 February 2025 Board meeting. The last time this benchmark rate was reduced was

    Read More
    Public
  • Recce Pharmaceuticals Accelerates Commercialisation with Strong Phase II Trial Results
    • News

    Recce Pharmaceuticals Accelerates Commercialisation with Strong Phase II Trial Results

    USD 26 Billion Market Opportunity The global market for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) is expected to grow from USD 7.3 billion in 2018 to USD 26 billion by 2032, highlighting an urgent need for effective new treatments. With the rise of antimicrobial resistance (AMR), demand for novel broad-spectrum antibiotics is at

    Read More
    Public
  • Infomedia Seizes AI Opportunity with 50% Stake in Intellegam
    • News

    Infomedia Seizes AI Opportunity with 50% Stake in Intellegam

    A Strategic Move into AI-Driven Automotive Solutions The automotive industry is at a turning point, driven by the rise of connected cars, changing customer expectations, and a need for efficiency. As businesses scramble for smarter solutions, Infomedia Ltd (ASX:IFM) has made a bold move—securing a 50% stake in European AI startup Intellegam GmbH for €6.1

    Read More
    Public
  • «
  • ‹
  • 20
  • 21
  • 22
  • 23
  • 24
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.